IM Cannabis (IMCC) Shares Outstanding (Weighted Average) (2019 - 2026)
IM Cannabis (IMCC) recorded quarterly Shares Outstanding (Weighted Average) of $197544.0 in Q1 2026, up 1.83% quarter-over-quarter from $193984.7 in Q4 2025, and up 6.96% on a YoY basis from $184682.9 in Q1 2025.
IM Cannabis (IMCC) Shares Outstanding (Weighted Average) (2019 - 2026) Analysis & Trends
IM Cannabis' Shares Outstanding (Weighted Average) history runs 8 years deep, the most recent figure standing at $197544.0 for Q1 2026.
- In Q1 2026, Shares Outstanding (Weighted Average) rose 6.96% year-over-year to $197544.0; the TTM figure through Mar 2026 stood at $197544.0 (up 6.96% YoY), while the FY2025 annual figure was $193984.7, down 91.39% from the prior year.
- Shares Outstanding (Weighted Average) was $197544.0 for Q1 2026 at IM Cannabis, up from $193984.7 in the prior quarter.
- In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $2.2 million in Q4 2024 to a low of $0.48 in Q2 2024.
- Historically, Shares Outstanding (Weighted Average) has averaged $429495.9 across 5 years, with a median of $190329.5 in 2022.
- The sharpest annual moves came in 2022 and 2024: Shares Outstanding (Weighted Average) surged 394439119.72% in 2022, then tumbled 99.13% in 2024.
- A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $929417.1 in 2022, then surged by 76.43% to $1.6 million in 2023, then soared by 34.7% to $2.2 million in 2024, then slumped by 91.22% to $193984.7 in 2025, then grew by 1.83% to $197544.0 in 2026.
- The last three Shares Outstanding (Weighted Average) figures came in at $197544.0 (Q1 2026), $193984.7 (Q4 2025), and $195881.9 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Weighted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 1.16 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 422.10 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 43.50 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 5.02 Bn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 100.50 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 497.70 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 166.20 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 64.74 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 228.36 Mn |
| 10 | IM Cannabis | 57,090.22 | -728,264.31 | 1.03 Mn | 197,544.01 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 197,544.01 |
| Dec 31, 2025 | 193,984.75 |
| Sep 30, 2025 | 195,881.90 |
| Jun 30, 2025 | 193,291.93 |
| Mar 31, 2025 | 184,682.87 |
| Dec 31, 2024 | 2.21 Mn |
| Sep 30, 2024 | 1,636.18 |
| Jun 30, 2024 | 0.48 |
| Mar 31, 2024 | 188,412.90 |
| Dec 31, 2023 | 1.64 Mn |
| Sep 30, 2023 | 187,344.17 |
| Mar 31, 2023 | 182,605.88 |
| Dec 31, 2022 | 929,417.06 |
| Sep 30, 2022 | 188,007.71 |
| Jun 30, 2022 | 189,682.59 |
| Mar 31, 2022 | 190,976.47 |
| Dec 31, 2021 | 900,653.03 |
| Sep 30, 2021 | 0.05 |
| Jun 30, 2021 | 0.08 |
| Mar 31, 2021 | 0.09 |